参考文献/References:
[1] Li X,Da Z,Ren X,et al.Trends and distribution of coronary heart disease mortality rate in Hexi Corridor,Gansu,China from 2006 to 2015[J].Rev Cardiovasc Med,2021,22:1003-1008.
[2]朱永新,张 颖,徐晓东.衰弱状态与老年冠心病患者PCI术后心功能及其预后[J].介入放射学杂志,2024,33:834-838.
[3]杨 晖,伍 锋,吴宗贵,等.活心丸(浓缩丸)治疗阳虚血瘀型经皮冠状动脉介入术后心绞痛的临床研究[J].中西医结合心脑血管病杂志,2023,21:775-779.
[4]张 闽,张东凤,田晋帆,等.尼可地尔联合单硝酸异山梨酯对冠状动脉慢性完全闭塞病变介入术后稳定型心绞痛的疗效[J].中国医药,2022,17:10-14.
[5]Liu Y,Zhang L,Yang Y.Tirofiban hydrochloride sodium chloride injection combined with cardiovascular intervention in the treatment of acute myocardial infarction[J].Pak J Med Sci,2020,36:54-58.
[6]Yamashita S Arai H,Bujo H,et al.Probucol trial for secondary prevention of atherosclerotic events in patients with coronary heart disease(PROSPECTIVE)[J].J Atheroscler Thromb,2021,28:103-123.
[7]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35:295-304.
[8]中华医学会心血管病学分会介入心脏病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,中华心血管病杂志编辑委员会.中国经皮冠状动脉介入治疗指南(2016)[J].中华心血管病杂志,2016,44:382-400.
[9]高润霖.心血管病治疗指南和建议[M].北京:人民军医出版社,2004:125-126.
[10]Lee YH,Fang J,Schieb L,et al.Prevalence and trends of coronary heart disease in the United States,2011 to 2018[J].JAMA Cardiol,2022,7:459-462.
[11]Wang SF,Wu TT,Zheng YY,et al.Serum globulin to albumin ratio as a novel predictor of adverse clinical outcomes in coronary artery disease patients who underwent PCI[J].Rev Cardiovasc Med,2023,24:278.
[12]Abdelhaq MJ,Shajrawi AM,Ismaile S,et al.Predictors of post-percutaneous coronary intervention chest pain among coronary heart disease patients[J].Clin Nurs Res,2023,32:1010-1020.
[13]孙雅萍,宋 杨.谷红注射液联合用药治疗冠心病患者PCI术后再发心绞痛的临床疗效及其对炎性因子和血管内皮功能的影响[J].辽宁中医杂志,2020,47:66-68.
[14]Ma Q,Ma Y,Wang X,et al.Intracoronary compared with intravenous bolus tirofiban on the microvascular obstruction in patients with STEMI undergoing PCI:a cardiac MR study[J].Int J Cardiovasc Imaging,2020,36:1121-1132.
[15]Tang X,Li RJ,Ma L,et al.Application of tirofiban in patients with acute myocardial infarction complicated with diabetes and undergoing emergency interventional therapy[J].Pak J Med Sci,2022,38:172-178.
[16]Pranata R,Yonas E,Vania R,et al.The role of probucol preventing contrast-induced nephropathy in patients undergoing invasive coronary procedures:systematic review and meta-analysis of randomized controlled trials[J].Turk Kardiyol Dern Ars,2021,49:51-59.
[17]卢 婧,王晓静,谭海龙,等.参芍片联合酒石酸美托洛尔片对冠心病心绞痛患者氧化应激、血管内皮功能和心肌损伤标志物的影响[J].现代生物医学进展,2022,22:3882-3886.
[18]Li X,Guo D,Zhou H,et al.Pro-inflammatory mediators and oxidative stress:therapeutic markers for recurrent angina pectoris after coronary artery stenting in elderly patients[J].Curr Vasc Pharmacol,2021,19:643-654.
[19]吴 乐,刘翠青,张 轩.丹参多酚酸盐对老年冠心病不稳定型心绞痛患者血管内皮功能的影响及机制分析[J].湖北中医药大学学报,2023,25:23-26.
[20]段丽萍,曹珮华,郭 倩,等.三种他汀类降脂方案治疗不稳定性心绞痛的疗效及其对患者炎症因子、血管内皮功能的影响[J].海南医学,2022,33:2885-2888.
(收稿日期:2024-07-30)
(本文编辑:新 宇)
相似文献/References:
[1]马东星,吴晓霞,马春梅,等.冠心病合并室间隔缺损／穿孔同期介入治疗成功二例[J].介入放射学杂志,2010,(08):624.
MA Dongxing,WU Xiaoxia,MA Chunmei,et al.Simultaneous performing of transcatheter closure of ventricular septal defect with rupture and percutaneous coronary intervention：report of two cases[J].J Intervent Med,2010,(06):624.
[2]何忆雯,秦永文,丁仲如.６４排螺旋CT冠脉成像在冠心病诊断中的应用[J].介入放射学杂志,2007,(01):10.
HE Yi-wen,QIN Yong-wen,DING Zhong-ru.Preliminary evaluation of６４-slice spiral CT coronary angiograpy in patients with coronary artery disease[J].J Intervent Med,2007,(06):10.
[3]倪靖炜,沈卫峰,张瑞岩,等.冠心病合并慢性肾功能不全患者的临床特征和PCI远期预后分析[J].介入放射学杂志,2007,(03):152.
NI Jing-wei,SHEN Wei-feng,ZHANG Rui-yan,et al.Clinical characteristics and long-term outcome of PCI in patients with chronic renal insufficiency[J].J Intervent Med,2007,(06):152.
[4]陈跃光,吕宝经.对比剂肾功能损害防治的研究进展[J].介入放射学杂志,2006,(06):382.
CHEN Yue-guang,LV Bao-jing.The effects of contrast medium on renal function in selective coronary angiography and intervention[J].J Intervent Med,2006,(06):382.
[5]肖红兵,张大东,顾俊.通心络对冠心病支架术后 C 反应蛋白及预后的影响[J].介入放射学杂志,2007,(08):520.
XIAO Hong-bing,ZHANG Da-dong,GU Jun.Effects of tongxinluo on C-reactive protein and clinical prognosis in patients after coronary stenting[J].J Intervent Med,2007,(06):520.
[6]徐迎佳,方唯一,杨向军.冠脉钙化小结血管内超声影像识别、发生率和分布特征[J].介入放射学杂志,2011,(08):606.
XU Ying-jia,FANG Wei-yi,YANG Xiang-jun..The occurrence and distribution features of calcified nodules in coronary arteries determined by intravascular ultrasonography[J].J Intervent Med,2011,(06):606.
[7]李郁芳,叶容珍,刘爱叶,等.改良国产YM-GU型动脉压迫止血器的临床应用[J].介入放射学杂志,2013,(07):599.
LI Yu? fang,YE Rong? zhen,LIU Ai? ye,et al.The clinical application of improved domestic YM?蛳 GU artery compression hemostatic device[J].J Intervent Med,2013,(06):599.
[8]吴 宁,蒲 红,王 娜,等.慢性完全闭塞冠状动脉患者介入术前双源CT评估及指导分析[J].介入放射学杂志,2014,(12):1069.
WU Ning,PU Hong,WANG Na,et al.Application of preoperative dual source CT angiography in evaluating chronic total occlusive coronary artery disease and in guiding interventional management[J].J Intervent Med,2014,(06):1069.
[9]邱向阳,梁 雨,李海燕.基于CiteSpace近10年冠心病介入治疗护理研究可视化分析[J].介入放射学杂志,2025,34(05):525.[doi:10.3969/j.issn.1008-794X.2025.05.015]
QIU Xiangyang,LIANG Yu,LI Haiyan..CiteSpace-based visualization analysis of 10-year study on interventional nursing care for coronary heart disease[J].J Intervent Med,2025,34(06):525.[doi:10.3969/j.issn.1008-794X.2025.05.015]
[10]田文静,蔡平凡,王 莹,等.改良式腰托联合骨科患肢制动固定装置的设计及肝癌介入术后应用[J].介入放射学杂志,2021,30(06):621.
TIAN Wenjing,CAI Pingfan,WANG Ying,et al.The design of improved lumbar support combined with orthopedic limb-immobilization device and its application in liver cancer patients after receiving interventional therapy[J].J Intervent Med,2021,30(06):621.